Moraes Fabio Ynoe, Bonifacio Lorine Arias, Neves-Junior Wellington Pimenta, Hanna Samir Abdallah, Abreu Carlos Eduardo Cintra Vita, Arruda Fernando Freire, Silva João Luis Fernandes, Carvalho Heloisa Andrade
Department of Radiation Oncology, Hospital Sírio-Libanês, São Paulo, SP, Brazil.
Department of Radiation Oncology and Medical Physics, Hospital Sírio-Libanês, São Paulo, SP, Brazil.
Rev Assoc Med Bras (1992). 2016 Nov;62(8):782-788. doi: 10.1590/1806-9282.62.08.782.
: To provide a quantitative profile of the indications and use of stereotactic body radiotherapy (SBRT) in a developing country oncology-based institution. In addition, to describe the patients' and treatment characteristics, and to provide a temporal analysis.
: SBRT patients treated from 2007 to 2015 were retrospectively evaluated by two independently investigators. Data were stratified and compared in two periods: first experience (FE) (May 2007 to April 2011), and following experience (FollowE) (May 2011 to April 2015). The following parameters were compared between the groups: total number of treated patients and lesions, treatment site, additional image fusion used, formal protocol adoption, and SBRT planning technique.
: One hundred and seventy-six (176) patients with 191 lesions were treated: 34 (18%) lesions in the FE and 157 (82%) lesions in FollowE. The majority of lesions were metastases (60.3%), and lung (60.2%) was the most common treatment site, followed by spine (31%), and others (8.8%). An average of 1.4 (±0.6) additional imaging exams for delineation was performed. Conformal 3D radiotherapy planning technique was used in 64.4%, and intensity modulated radiotherapy (IMRT) or volumetric-modulated arc therapy (VMAT) in the remaining 35.6% (p=0.0001). Higher rates of curative treatments were observed in FE, as well as more lung lesions, patients ≥ 70 years, 3D conformal, number of additional images and ECOG 0, and all presented p<0.05. The global rate of protocol statement was 79%, lung treatment being the most stated.
: SBRT application is rapidly increasing in our setting. Treatment sites and planning techniques are becoming more diversified and complex.
对发展中国家一家肿瘤专科医院立体定向体部放射治疗(SBRT)的适应证及应用情况进行定量分析。此外,描述患者及治疗特征,并进行时间分析。
由两名独立研究人员对2007年至2015年接受SBRT治疗的患者进行回顾性评估。数据分为两个时期进行分层比较:首次经验期(FE)(2007年5月至2011年4月)和后续经验期(FollowE)(2011年5月至2015年4月)。比较两组间以下参数:治疗患者和病灶总数、治疗部位、额外使用的图像融合、正式方案采用情况以及SBRT计划技术。
共治疗176例患者,191个病灶:FE期34个(18%)病灶,FollowE期157个(82%)病灶。大多数病灶为转移瘤(60.3%),最常见的治疗部位是肺部(60.2%),其次是脊柱(31%),其他部位(8.8%)。平均进行1.4(±0.6)次额外的成像检查用于勾画。64.4%使用适形3D放射治疗计划技术,其余35.6%使用调强放射治疗(IMRT)或容积调强弧形治疗(VMAT)(p = 0.0001)。FE期观察到更高的根治性治疗率,以及更多的肺部病灶、≥70岁患者、3D适形、额外图像数量和东部肿瘤协作组(ECOG)0分的患者,所有这些p均<0.05。方案声明的总体率为79%,肺部治疗声明最多。
在我们的机构中,SBRT的应用正在迅速增加。治疗部位和计划技术正变得更加多样化和复杂。